Lars Boesgaard - 12 Jan 2026 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role: Chief Financial Officer
Signature: /s/ Lars Boesgaard
Issuer symbol: PDSB
Transactions as of: 12 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 03 Mar 2026, 18:47:29 UTC
Previous filing: 25 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Boesgaard Lars	Chief Financial Officer	C/O PDS BIOTECHNOLOGY CORPORATION, 303A COLLEGE ROAD EAST, PRINCETON	/s/ Lars Boesgaard	03 Mar 2026	0001403893

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PDSB	Employee Stock Option (Right to Buy)	Award	$0	+300,000		$0.000000	300,000	12 Jan 2026	Common Stock	300,000	$0.9800	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.